Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 63 (6), 297-302
- https://doi.org/10.1016/s0010-7824(01)00208-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A survey of american women regarding the use of oral contraceptives and weight gainInternational Journal of Gynecology & Obstetrics, 2000
- Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparationsContraception, 1999
- Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)American Journal of Obstetrics and Gynecology, 1999
- Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidenceContraception, 1999
- International clinical experience with a new low-dose, Monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μgClinical Therapeutics, 1999
- Weight change with oral contraceptive use and during the menstrual cycleContraception, 1998
- A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cyclesContraception, 1997
- Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young womenFertility and Sterility, 1995
- Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patientsAmerican Journal of Obstetrics and Gynecology, 1992
- A comparative analysis of three different dose combinations of oral contraceptivesContraception, 1989